Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 11, 2011, Pages 1391-1398

  Lopez Rojas R ^a,e   Docobo Perez F ^a   Pachon Ibanez M E ^a   De La Torre, B G ^b   Fernandez Reyes M ^c   March, C ^d   Bengoechea, J A ^d   Andreu, D ^b   Rivas, L ^c   Pachon J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CECROPIN A MELITTIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG PERITONEAL FLUID LEVEL; FEMALE; HYDROPHOBICITY; IN VIVO STUDY; LD 50; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ASCITIC FLUID; DRUG RESISTANCE, BACTERIAL; ERYTHROCYTES; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MELITTEN; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MODELS, ANIMAL; RECOMBINANT FUSION PROTEINS; SEPSIS; SPLEEN; TIME FACTORS;

EID: 80054765261     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1233-y     Document Type: Article

References (40)

1. J Rodriguez-Bano JM Cisneros F Fernandez-Cuenca A Ribera J Vila A Pascual L Martinez-Martinez G Bou J Pachon 2004 Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals Infect Control Hosp Epidemiol 25 819 824 15518022 10.1086/502302 (Pubitemid 40036756)
2. J Vila J Pachon 2008 Therapeutic options for Acinetobacter baumannii infections Expert Opin Pharmacother 9 587 599 18312160 10.1517/14656566.9.4.587 1:CAS:528:DC%2BD1cXksF2ru7w%3D (Pubitemid 351425386)
3. PE Fournier H Richet 2006 The epidemiology and control of Acinetobacter baumannii in health care facilities Clin Infect Dis 42 692 699 16447117 10.1086/500202 (Pubitemid 43271386)
4. MV Villegas AI Hartstein 2003 Acinetobacter outbreaks, 1977-2000 Infect Control Hosp Epidemiol 24 284 295 12725359 10.1086/502205 (Pubitemid 36538142)
5. L Poirel P Nordmann 2006 Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology Clin Microbiol Infect 12 826 836 16882287 10.1111/j.1469-0691.2006.01456.x 1:CAS:528:DC%2BD28XhtVeht7bP (Pubitemid 44151282)
6. KJ Towner K Levi M Vlassiadi 2008 Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe Clin Microbiol Infect 14 161 167 18093236 10.1111/j.1469-0691.2007.01911.x 1:STN:280:DC%2BD1c7islekug%3D%3D
7. R Valencia LA Arroyo M Conde JM Aldana MJ Torres F Fernandez-Cuenca J Garnacho-Montero JM Cisneros C Ortiz J Pachon J Aznar 2009 Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital Infect Control Hosp Epidemiol 30 257 263 19199531 10.1086/595977
8. T Ganz 2004 Defensins: antimicrobial peptides of vertebrates C R Biol 327 539 549 15330253 10.1016/j.crvi.2003.12.007 1:CAS:528:DC%2BD2cXls1Wlt7s%3D (Pubitemid 38979504)
9. A Giuliani SF Nicoletto 2007 Antimicrobial peptides: an overview of a promising class of therapeutics Cent Eur J Biol 2 33 10.2478/s11535-007-0010-5 (Pubitemid 46450753)
10. H Jenssen P Hamill RE Hancock 2006 Peptide antimicrobial agents Clin Microbiol Rev 19 491 511 16847082 10.1128/CMR.00056-05 1:CAS:528: DC%2BD28XosVaqsrk%3D (Pubitemid 44137212)
11. H Khandelia JH Ipsen OG Mouritsen 2008 The impact of peptides on lipid membranes Biochim Biophys Acta 1778 1528 1536 18358231 10.1016/j.bbamem.2008.02. 009 1:CAS:528:DC%2BD1cXnsFCrs7k%3D
12. K Matsuzaki 2009 Control of cell selectivity of antimicrobial peptides Biochim Biophys Acta 1788 1687 1692 18952049 10.1016/j.bbamem.2008.09.013 1:CAS:528:DC%2BD1MXnt1Ghtbg%3D
13. Rivas L, Andreu D (2003) Cecropin-melittin hybrid peptides as versatile templates in the development of membrane active antibiotics agents. In: Menestrina G, Dalla Serra M (eds) Pore-forming peptides and protein toxins. Harwood Academic Publishers, Reading, Berkshire, United Kingdom, pp 215-259
14. A Giacometti O Cirioni R Ghiselli F Mocchegiani G D'Amato MS Del Prete F Orlando W Kamysz J Lukasiak V Saba G Scalise 2003 Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats Gut 52 874 878 12740345 10.1136/gut.52.6.874 1:CAS:528:DC%2BD3sXkvFCiurY%3D (Pubitemid 36613496)
15. R Ghiselli A Giacometti O Cirioni F Orlando F Mocchegiani AM Pacci G Scalise V Saba 2001 Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia J Surg Res 100 183 188 11592790 10.1006/jsre.2001.6235 1:CAS:528:DC%2BD3MXntlOksLc%3D (Pubitemid 32989360)
16. A Giuliani G Pirri A Bozzi A Di Giulio M Aschi AC Rinaldi 2008 Antimicrobial peptides: natural templates for synthetic membrane-active compounds Cell Mol Life Sci 65 2450 2460 18661101 10.1007/s00018-008-8188-x 1:CAS:528:DC%2BD1cXhtVansr3E
17. I Zelezetsky A Tossi 2006 Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies Biochim Biophys Acta 1758 9 1436 1449 16678118 10.1016/j.bbamem.2006.03.021 1:CAS:528:DC%2BD28XhtVanu7bF (Pubitemid 44436080)
18. D Andreu J Ubach A Boman B Wahlin D Wade RB Merrifield HG Boman 1992 Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity FEBS Lett 296 2 190 194 1733777 10.1016/0014-5793(92)80377- S 1:CAS:528:DyaK38Xht1Cktrk%3D
19. HC Boman IA Boman D Andreu ZQ Li RB Merrifield G Schlenstedt R Zimmermann 1989 Chemical synthesis and enzymic processing of precursor forms of cecropins A and B J Biol Chem 264 10 5852 5860 2925637 1:CAS:528:DyaL1MXkt1Wqurw%3D (Pubitemid 19098053)
20. L Cavallarin D Andreu B San Segundo 1998 Cecropin A-derived peptides are potent inhibitors of fungal plant pathogens Mol Plant Microbe Interact 11 3 218 227 9487696 10.1094/MPMI.1998.11.3.218 1:CAS:528:DyaK1cXht12hur4%3D (Pubitemid 28091698)
21. C Chicharro C Granata R Lozano D Andreu L Rivas 2001 N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide Antimicrob Agents Chemother 45 9 2441 2449 11502512 10.1128/AAC.45.9.2441-2449.2001 1:CAS:528:DC%2BD3MXmt1emsLs%3D (Pubitemid 32801893)
22. C Friedrich MG Scott N Karunaratne H Yan RE Hancock 1999 Salt-resistant alpha-helical cationic antimicrobial peptides Antimicrob Agents Chemother 43 7 1542 1548 10390200 1:CAS:528:DyaK1MXktlCksr0%3D (Pubitemid 29331225)
23. MJ Rodriguez-Hernandez J Saugar F Docobo-Perez BG de la Torre ME Pachon-Ibanez A Garcia-Curiel F Fernandez-Cuenca D Andreu L Rivas J Pachon 2006 Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii J Antimicrob Chemother 58 1 95 100 16636085 10.1093/jac/dkl145 1:CAS:528:DC%2BD28Xms1Ogsb0%3D (Pubitemid 44294991)
24. JM Saugar MJ Rodriguez-Hernandez BG de la Torre ME Pachon-Ibanez M Fernandez-Reyes D Andreu J Pachon L Rivas 2006 Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action Antimicrob Agents Chemother 50 4 1251 1256 16569836 10.1128/AAC.50.4.1251-1256.2006 1:CAS:528:DC%2BD28XjvFOku7o%3D
25. C57BL/6 Datasheet. Harland. http://www.harlan.com/research-models-and- services/research-models-by-product-type/inbred-mice/c57bl6j-inbred-mice.hl.
26. BALBc Datasheet. Harland. http://www.harlan.com/research-models-and- services/research-models-by-product-type/inbred-mice/balbc.hl. Accessed 13 December 2010.
27. C Solanas BG de la Torre M Fernandez-Reyes CM Santiveri MA Jimenez L Rivas AI Jimenez D Andreu C Cativiela 2009 Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn J Med Chem 52 3 664 674 19132829 10.1021/jm800886n 1:CAS:528:DC%2BD1MXktVOlug%3D%3D
28. O'Reilly T, Cleeland R, Squires EL (1996) Evaluation of antimicrobials in experimental animal infections. In: Lorian V (ed) Antibiotics in laboratory medicine. Williams and Wilkins, MD, USA, pp 604-765
29. J Pachon J Vila 2009 Treatment of multiresistant Acinetobacter baumannii infections Curr Opin Investig Drugs 10 2 150 156 19197792 1:CAS:528: DC%2BC3cXnt1KitLk%3D
30. HA Pereira 2006 Novel therapies based on cationic antimicrobial peptides Curr Pharm Biotechnol 7 4 229 234 16918399 10.2174/138920106777950771 1:CAS:528:DC%2BD28Xpt1Sgtbs%3D (Pubitemid 44194383)
31. L Zhang TJ Falla 2006 Antimicrobial peptides: therapeutic potential Expert Opin Pharmacother 7 6 653 663 16556083 10.1517/14656566.7.6.653 1:CAS:528:DC%2BD28XivVOnurk%3D
32. A Braunstein N Papo Y Shai 2004 In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria Antimicrob Agents Chemother 48 8 3127 3129 15273131 10.1128/AAC.48.8.3127-3129.2004 1:CAS:528:DC%2BD2cXmtlKqtLo%3D (Pubitemid 38989185)
33. A Giacometti O Cirioni W Kamysz G D'Amato C Silvestri MS Del Prete J Lukasiak G Scalise 2003 Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii Peptides 24 9 1315 1318 14706545 10.1016/j.peptides.2003.08.003 1:CAS:528:DC%2BD2cXptFaj (Pubitemid 38045538)
34. JM Saugar T Alarcon S Lopez-Hernandez M Lopez-Brea D Andreu L Rivas 2002 Activities of polymyxin B and cecropin A-, melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii Antimicrob Agents Chemother 46 3 875 878 11850277 10.1128/AAC.46.3.875-878.2002 1:CAS:528:DC%2BD38XhsVKhu70%3D (Pubitemid 34157679)
35. D Avrahami Y Shai 2003 Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D, L-amino acid-containing antimicrobial peptides: a plausible mode of action Biochemistry 42 50 14946 14956 14674771 10.1021/bi035142v 1:CAS:528:DC%2BD3sXpt1Wqsr0%3D (Pubitemid 37553525)
36. M Gough RE Hancock NM Kelly 1996 Antiendotoxin activity of cationic peptide antimicrobial agents Infect Immun 64 12 4922 4927 8945527 1:CAS:528:DyaK28XntFymu7g%3D (Pubitemid 26403942)
37. L Zhang T Falla M Wu S Fidai J Burian W Kay RE Hancock 1998 Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria Biochem Biophys Res Commun 247 3 674 680 9647752 10.1006/bbrc.1998.8848 1:CAS:528:DyaK1cXkt12hurg%3D (Pubitemid 28418450)
38. D Seebach AK Beck DJ Bierbaum 2004 The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components Chem Biodivers 1 8 1111 1239 17191902 10.1002/cbdv.200490087 1:CAS:528: DC%2BD2cXnslCktb0%3D
39. L Zhang R Benz RE Hancock 1999 Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides Biochemistry 38 25 8102 8111 10387056 10.1021/bi9904104 1:CAS:528:DyaK1MXjtlWqs7s%3D (Pubitemid 29302384)
40. KL Piers MH Brown RE Hancock 1994 Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification Antimicrob Agents Chemother 38 10 2311 2316 7840562 1:CAS:528:DyaK2cXmsFWjtLs%3D (Pubitemid 24304222)